|
|||||
|
|
Erlotinib in the treatment of recurrent or metastatic cutaneous squamous cell carcinoma: A single‐arm phase 2 clinical trial |
|
| Authors: | Kathryn A. Gold MD Merrill S. Kies MD William N. William MD Jr Faye M. Johnson MD PhD J. Jack Lee PhD Bonnie S. Glisson MD |
| Affiliation: | 1. Division of Hematology and Oncology, Moores Cancer Center, University of California–San Diego, La Jolla, California;2. Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas;3. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| Abstract: | |
| Keywords: | squamous cell carcinoma skin cancer erlotinib epidermal growth factor receptor anti‐neoplastic agents |